China SXT Pharmaceuticals News

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(5,42%)

May 31 09:38

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 14 15:21

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 5 08:28

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(2,38%)

Feb 9 09:20

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forsakringsaktiebolaget Avanza Pension(5,07%)

Feb 9 05:39

China SXT Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 10 23:00

China SXT Pharmaceuticals | 20-F: FY2023 Annual Report

Jul 31, 2023 15:15

China SXT Pharmaceuticals | UPLOAD: Others

Jun 2, 2023 10:33

China SXT Pharmaceuticals | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

May 19, 2023 16:16

China SXT Pharmaceuticals | CORRESP: CORRESP

Apr 13, 2023 16:25

China SXT Pharmaceuticals | UPLOAD: Others

Mar 31, 2023 12:30

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.

Mar 29, 2023 13:19

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(0%),Streeterville Management LLC(0%), etc.

Mar 29, 2023 12:48

China SXT Pharmaceuticals | 424B7: Prospectus

Mar 24, 2023 17:54

China SXT Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Mar 23, 2023 05:02

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 28, 2023 15:05

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 24, 2023 16:15

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 13, 2023 15:28

China SXT Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Feng Zhou(21.498%),Zhijun Xiao(20.179%)

Jan 30, 2023 15:05

China SXT Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Dec 22, 2022 20:20